Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection

This document is a response-to-comments notice for MolDX LCD L38671, recording a title change to 'MolDX: Molecular Testing for Solid Organ Allograft Rejection' and providing comment/notice/effective dates. The supplied text does not include any clinical coverage criteria, limitations, frequency limits, or claims documentation requirements; the full LCD L38671 should be reviewed for actionable coverage criteria.

"LCD L38671 notice period begins 2021-05-20 and becomes effective 2021-07-04; comment period ran 2020-05-28 to 2020-07-12."

Sign up to see full coverage criteria, indications, and limitations.